Sort by: Article Title Contributor Topic Date

Is The California Land Rush On Again?

Despite the earthquake that tumbled prices in the East, California real estate-faults and all-is on the rebound.

Michael T. Harris June 1 1990

Under The Knife

A 50/50 sharing of costs would make employers careful shoppers for their health insurance and employees careful shoppers for their medical care.

Rita Ricardo-campbell June 1 1990

Executive Quirks II

Four years ago CE collected a random sampling of idiosyncrasies about CEOs. In this, our second look at this phenomenon, we find that some CEOs are, indeed, getting quirkier.

Amaid Josef Finkelthal June 1 1990


Gringo bashing may be on the wane in restructured South American economies. But the link between billionaire cocaine barons and leftist guerrillas means that multinational executives still face deadly competition.

Theodore G. Shackley And R.A. Finney And R.L. Oat June 1 1990

Nice Guys Get Things Done Too

So the Commerce Department (or DARPA for that matter) won’t become a U.S.-style MITI or ersatz venture capitalist after all. But under Robert Mosbacher it is becoming a facilitator and market opener. Do nice guys win policy disputes?

Chief Executive June 1 1990

Top Management’s Selling Role

In the competitive decade of the 1990s, when customers are “partnering” with fewer suppliers and expecting better quality and service, CEOs may be forced to brush up on their selling skills.

Roy Serpa And Donald W. Jackson June 1 1990

How Much, Where, And Why

In the following international CEO compensation survey, two major trends stand out: The pay gap between U.S. and non-U.S. CEOs is narrowing; and the restructuring and increased foreign ownership of U.S. firms is introducing a dose of reality into the compensation process.

Brain Dunn And James E. Keilley June 1 1990


GNP-GIVES NO POWERThe increasing spread of economic capability and interdependence makes it less likely than ever that anyone will be [...]

Chief Executive June 1 1990

Glaxo Goes It Alone

Today it costs on average $160 million to bring a new drug to market, up from $125 million lust three years ago. No wonder most pharmaceutical companies are scrambling to combine-most, but not all.

Chief Executive June 1 1990

Maurice G. Hardy

Only serious environmental incidents like the recent-and costly-Perrier debacle remind most of us of the crucial importance of the “fluid [...]

Peter Lacey June 1 1990

Free Newsletters

Sign up now to receive our free e-newsletters. You can choose to receive our weekly CEO Briefing updates, monthly Entrepreneurial CEO newsletter, and exclusive CEO surveys.